Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
An update from Paragon Care Limited ( (AU:PGC) ) is now available.
Paragon Care Limited announced a change in the director’s interest, with Carmen Riley acquiring 2,247,877 Performance Rights, as approved in the company’s Annual General Meeting on November 21, 2024. This change reflects the company’s ongoing commitment to aligning its leadership’s interests with its strategic goals, potentially impacting its market positioning and stakeholder confidence positively.
The most recent analyst rating on (AU:PGC) stock is a Buy with a A$0.52 price target. To see the full list of analyst forecasts on Paragon Care Limited stock, see the AU:PGC Stock Forecast page.
More about Paragon Care Limited
Paragon Care Limited operates in the healthcare sector, providing a range of medical equipment, devices, and services. The company focuses on delivering innovative healthcare solutions to enhance patient care and operational efficiency in medical facilities.
YTD Price Performance: -26.04%
Average Trading Volume: 628,367
Technical Sentiment Signal: Hold
Current Market Cap: A$587.6M
See more data about PGC stock on TipRanks’ Stock Analysis page.